Related Experiment Videos
The PD-1-PD-L pathway in immunological tolerance.
121st Century Center of Excellence Program, Graduate School of Medicine, Kyoto University, Yoshida-Konoe, Sakyo-ku, Kyoto, 606-8501, Japan.
Trends in Immunology
|February 28, 2006
Summary
Programmed cell death 1 (PD-1) plays a crucial role in preventing autoimmune diseases by maintaining immune tolerance. PD-1 regulates tolerance by suppressing self-reactive T cells and protecting tissues from immune attack.
Area of Science:
- Immunology
- Autoimmunity research
- Molecular biology
Background:
- Programmed cell death 1 (PD-1) is implicated in regulating autoimmunity, but its precise mechanisms remain unclear.
- Spontaneous autoimmune diseases observed in PD-1 knockout mice highlight its importance.
Purpose of the Study:
- To review recent findings on the role of PD-1 in immunological tolerance.
- To discuss potential clinical applications of manipulating PD-1 pathways.
Main Methods:
- Review of recent scientific literature on PD-1 function in immune tolerance.
- Analysis of studies investigating PD-1 ligands (PD-Ls) and their interactions with T cells.
- Examination of collaborative roles between PD-1 and other immuno-inhibitory receptors.
Main Results:
- PD-1 exhibits dual roles in immunological tolerance: inducing and maintaining peripheral tolerance.
- PD-Ls on antigen-presenting cells suppress autoreactive T cells, promoting tolerance.
- PD-Ls on parenchymal cells inhibit effector T cells, preventing tissue damage and maintaining tolerance.
Conclusions:
- PD-1 is essential for both the induction and maintenance of peripheral immune tolerance.
- PD-1 collaborates with other inhibitory receptors to regulate immune responses.
- Targeting PD-1 pathways offers promising avenues for clinical applications in autoimmune diseases.